PUBLISHER: The Business Research Company | PRODUCT CODE: 2165625
PUBLISHER: The Business Research Company | PRODUCT CODE: 2165625
Real-time follicle counting AI ultrasound probe refers to a technology-enabled medical imaging solution that enables clinicians to evaluate and count ovarian follicles in real time using an ultrasound probe integrated with artificial intelligence. Its main purpose is to improve the accuracy and efficiency of fertility assessments while reducing manual intervention and variations in follicle evaluation. It also supports better clinical decision-making, reduces examination duration, improves patient outcomes, and contributes to the digital transformation of reproductive healthcare services.
The primary components of real-time follicle counting AI ultrasound probes include hardware, software, and services. Hardware consists of ultrasound probes fitted with imaging sensors and integrated artificial intelligence capabilities that facilitate the automated real-time identification, measurement, and counting of ovarian follicles during fertility assessments. These systems incorporate technologies such as two dimensional ultrasound, three dimensional or four dimensional ultrasound, and other technologies. The key applications include follicle monitoring for in vitro fertilization, polycystic ovary syndrome assessment, ovarian reserve testing, fertility preservation evaluation, and gynecological research, and these systems are used by end users including fertility clinics, hospitals, diagnostic imaging centers, and research institutes.
Tariffs are influencing the real-time follicle counting AI ultrasound probe market by raising the cost of imported ultrasound components, semiconductor chips, imaging sensors, and AI-enabled hardware required for sophisticated fertility imaging systems. These cost pressures are affecting hardware-intensive products such as ultrasound imaging probes, portable ultrasound devices, and high-resolution transducers, particularly across import-dependent regions including North America, Europe, and Asia-Pacific. Higher equipment expenses may limit or delay adoption among fertility clinics and diagnostic imaging centers. However, tariffs are also promoting domestic manufacturing, regional sourcing approaches, and investment in locally developed medical imaging technologies, which can enhance long-term supply chain stability.
The real-time follicle counting ai ultrasound probe market research report is one of a series of new reports from The Business Research Company that provides real-time follicle counting ai ultrasound probe market statistics, including real-time follicle counting ai ultrasound probe industry global market size, regional shares, competitors with a real-time follicle counting ai ultrasound probe market share, detailed real-time follicle counting ai ultrasound probe market segments, market trends and opportunities, and any further data you may need to thrive in the real-time follicle counting ai ultrasound probe industry. This real-time follicle counting ai ultrasound probe market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The real-time follicle counting ai ultrasound probe market size has grown rapidly in recent years. It will grow from $0.49 billion in 2025 to $0.55 billion in 2026 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to rising demand for fertility diagnostic solutions, increasing adoption of assisted reproductive technologies, growing incidence of infertility conditions, expanding fertility clinic infrastructure, and increasing need for precise follicle monitoring.
The real-time follicle counting ai ultrasound probe market size is expected to see rapid growth in the next few years. It will grow to $0.91 billion in 2030 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to increasing adoption of AI-powered ultrasound analysis, rising demand for real-time fertility monitoring solutions, growing emphasis on minimizing diagnostic variability, expanding digital transformation across reproductive healthcare, increasing investment in advanced medical imaging technologies. Major trends in the forecast period include growing adoption of AI-based fertility imaging solutions, increasing demand for automated follicle assessment technologies, rising integration of real-time ultrasound diagnostic capabilities, expanding digital reproductive healthcare workflows, increasing focus on enhancing the accuracy of fertility treatments.
The rise in infertility cases globally is expected to propel the growth of the real-time follicle counting AI ultrasound probe market going forward. Infertility is a disease of the male or female reproductive system, defined by the inability to achieve a pregnancy after 12 months or more of regular unprotected sexual intercourse. Globally, infertility cases continue to rise as women increasingly delay childbearing due to career prioritization and changing social norms, reducing natural conception rates among individuals of reproductive age. This growing patient population increases demand for precise, technology-driven fertility diagnostics, and real-time follicle counting AI ultrasound probes directly address this need by enabling clinicians to evaluate ovarian follicle development with greater speed and accuracy, thereby supporting more effective assisted reproductive technology (ART) treatment decisions. For instance, in April 2023, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, approximately 17.5% of the adult population, or about 1 in 6 people globally, experience infertility, emphasizing the urgent need to improve access to affordable, high-quality fertility care for those affected. Therefore, the rise in infertility cases globally is driving the growth of the real-time follicle counting AI ultrasound probe market.
Key companies operating in the real-time follicle counting AI ultrasound probe market are focusing on integrating AI-powered follicle assessment and automation capabilities into ultrasound systems to improve imaging accuracy, streamline fertility workflows, and reduce operator dependency. AI-powered follicle assessment uses deep learning algorithms to automatically detect, count, measure, and monitor ovarian follicles in real time, supporting faster and more consistent fertility evaluations. For example, in January 2025, GE HealthCare Technologies Inc., a US-based medical technology company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its updated Voluson Expert Series ultrasound systems, including Voluson Expert 22, 20, and 18. The systems incorporate AI-powered automation features, including SonoAVC Follicle 2.0, which enables automated ovarian follicle detection, counting, and measurement to enhance workflow efficiency, imaging performance, and clinical decision-making in fertility assessment and assisted reproductive procedures.
In June 2025, Cycle Clarity, a US-based fertility technology company, entered into a partnership with Artisan to integrate Cycle Clarity's AI-powered follicular monitoring data and insights directly into Artisan's electronic medical record platform, facilitating automated data transfer and more efficient fertility clinic operations. Through this collaboration, the companies seek to eliminate manual data entry, enhance access to real-time fertility monitoring information, decrease administrative and nursing workloads, and enable more efficient and individualized patient care. Artisan is a US-based cloud-based technology company that offers electronic medical record solutions specifically developed for fertility practices, supporting clinical operations, patient communication, and integration with ultrasound systems and other fertility-care technologies.
Major companies operating in the real-time follicle counting ai ultrasound probe market are Siemens Healthineers AG, GE HealthCare Technologies Inc., Philips Healthcare, Fujifilm Holdings Corporation, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Canon Medical Systems Corporation, Samsung Medison, Esaote S.p.A., Shenzhen SonoScape Medical Corp., Edan Instruments Inc., CHISON Medical Technologies Co. Ltd., Alpinion Medical Systems Co. Ltd., Butterfly Network Inc., Terason, Clarius Mobile Health Corp., Exo Imaging Inc., Pulsenmore Ltd., Cycle Clarity Inc., Alife Health Inc., VinBrain (VinDr AI)
North America was the dominant region in the real-time follicle counting ai ultrasound probe market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the real-time follicle counting ai ultrasound probe market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the real-time follicle counting ai ultrasound probe market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The real-time follicle counting AI ultrasound probe market consists of revenues earned by entities by providing services such as AI-assisted follicle detection and counting, automated follicle measurement and tracking, ovarian reserve assessment, fertility treatment monitoring, ultrasound imaging and interpretation, cloud-based image analysis, and clinical workflow integration. The market value includes the value of related goods sold by the service provider or included within the service offering. The real-time follicle counting AI ultrasound probe market also includes sales of AI-enabled ultrasound probes, ultrasound imaging systems, transvaginal ultrasound transducers, portable ultrasound devices, image processing workstations, and fertility imaging accessories. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Real-Time Follicle Counting AI Ultrasound Probe Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses real-time follicle counting ai ultrasound probe market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for real-time follicle counting ai ultrasound probe ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The real-time follicle counting ai ultrasound probe market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.